Design, Synthesis, and Evaluation of Cephamycin-Based Antisporulation Agents targeting Clostridioides difficile.
Saved in:
| Title: | Design, Synthesis, and Evaluation of Cephamycin-Based Antisporulation Agents targeting Clostridioides difficile. |
|---|---|
| Authors: | Cun WY; School of Chemistry and Molecular Bioscience, Molecular Horizons Research Institute, University of Wollongong, Wollongong 2522 New South Wales, Australia., Bate CE; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton 3800, Victoria, Australia.; Centre to Impact AMR, Monash University, Clayton 3800, Victoria Australia., Srikhanta YN; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton 3800, Victoria, Australia.; Centre to Impact AMR, Monash University, Clayton 3800, Victoria Australia., Hutton ML; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton 3800, Victoria, Australia.; Centre to Impact AMR, Monash University, Clayton 3800, Victoria Australia., Webb CT; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton 3800, Victoria, Australia.; Centre to Impact AMR, Monash University, Clayton 3800, Victoria Australia., Revitt-Mills SA; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton 3800, Victoria, Australia.; Centre to Impact AMR, Monash University, Clayton 3800, Victoria Australia., Lyras D; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton 3800, Victoria, Australia.; Centre to Impact AMR, Monash University, Clayton 3800, Victoria Australia., McGowan S; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton 3800, Victoria, Australia.; Centre to Impact AMR, Monash University, Clayton 3800, Victoria Australia., Yu H; School of Chemistry and Molecular Bioscience, Molecular Horizons Research Institute, University of Wollongong, Wollongong 2522 New South Wales, Australia.; ARC Centre of Excellence in Quantum Biotechnology, University of Wollongong, Wollongong 2522 New South Wales, Australia., Keller PA; School of Chemistry and Molecular Bioscience, Molecular Horizons Research Institute, University of Wollongong, Wollongong 2522 New South Wales, Australia., Pyne SG; School of Chemistry and Molecular Bioscience, Molecular Horizons Research Institute, University of Wollongong, Wollongong 2522 New South Wales, Australia. |
| Source: | Journal of medicinal chemistry [J Med Chem] 2024 Jan 11; Vol. 67 (1), pp. 450-466. Date of Electronic Publication: 2023 Dec 19. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
